Autopsy report · NCT04115098

Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials

“lack of recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 3 years 2 months before it stopped.
• 42 participants enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

The University of Texas Health Science Center, Houston

Sponsor type

University, hospital or other

Conditions

Axial Spondyloarthritis

Interventions

Celecoxib; Naproxen; Meloxicam

Participants

42

Sites

1

Countries

United States

Trials that died the same way

• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  “lacking recruitment” (96% match in meaning)
• Intrauterine Device Insertion Pain Management
  “Inadequate recruitment” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.